Express News | NYSE Order Imbalance 481624.0 Shares on Buy Side
Healthpeak Properties to Present at Nareit's REITweek 2024 Investor Conference
Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, President and Chief Executive Officer, and Peter
Express News | NYSE Order Imbalance 122711.0 Shares on Sell Side
Express News | NYSE Order Imbalance 118487.0 Shares on Sell Side
Express News | NYSE Order Imbalance 144895.0 Shares on Sell Side
Are Wall Street Analysts Bullish on Healthpeak Properties Stock?
Real Estate Stocks Fall After 4 Weeks of Gain as Rate Cut Hopes Dampen
Express News | NYSE Order Imbalance 50520.0 Shares on Buy Side
Real Estate Stocks Continue to Surge as Soft Inflation Reports Fuel Rate Cut Hopes
J.P. Morgan Sticks to Their Hold Rating for Healthpeak Properties (DOC)
Cracking The Code: Understanding Analyst Reviews For Healthpeak Properties
Analysts' ratings for Healthpeak Properties (NYSE:DOC) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The table below provides a snapshot of their recent ratings, showca
Scotiabank Maintains Sector Outperform on Healthpeak Properties, Raises Price Target to $23
Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties with a Sector Outperform and raises the price target from $22 to $23.
Healthpeak Properties Is Maintained at Neutral by JP Morgan
Healthpeak Properties Is Maintained at Neutral by JP Morgan
Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.
Komo: Maintaining the Healthpeak Properties (DOC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $19.00 to $21.00.
JPMorgan Adjusts Price Target on Healthpeak Properties to $21 From $19, Keeps Neutral Rating
Healthpeak Properties (DOC) has an average rating of outperform and price targets ranging from $18 to $30.50, according to analysts polled by Capital IQ. Price: 20.36, Change: +0.11, Percent Change: +
Real Estate Stocks Continue to Outperform Broader Markets With Increased Chances of Rate Cut
Argus Research Keeps Their Buy Rating on Healthpeak Properties (DOC)
Healthpeak Properties Announces Joint Venture Wind-Down
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak") and King Street Properties ("KSP") today announced that Healthpeak has acquired KSP's minority interest in the joint ven
BMO Capital Adjusts Price Target on Healthpeak Properties to $23 From $21, Keeps Outperform Rating
Healthpeak Properties (DOC) has an average rating of outperform and price targets ranging from $18 to $30.50, according to analysts polled by Capital IQ. Price: 18.99, Change: +0.02, Percent Change: +
Real Estate Stocks Outperform Major Market Averages as Rate Hikes Are Ruled Out, Earnings Continue to Grow
Real estate stocks outperformed major market averages as the Federal Reserve ruled out a near-term rate hike despite the inflation data, and the sector continued to demonstrate solid balance sheets and earnings.
No Data